ANGELA LARSON is a Managing Director in the Equity Research Department
at C.E. Unterberg, Towbin, where she covers the specialty pharmaceutical
industry. Previously, she covered the same sector while part of the U.S.
Equity Research Department at Smith Barney (2000-2004) and as an Analyst
at PaineWebber (1997-2000). Prior to that, she was an Associate Analyst
at PaineWebber with the US large cap pharmaceutical team. Prior to
joining the Street, she worked in business development and was a
Strategic Planning Analyst at Hoffman-La Roche. She has been mentioned
in the Institutional Investor All-American Research Team polls for the
last four years (number three in 2003 and 2002, number two in 2001 and
‘Up and Comer’ in 2000). She has an MS in Health Economics from Johns
Hopkins University and a BA in Economics from Boise State University.